Transferrin Receptor 2 in Canine Testicular Tumors: An Emerging Key Role in Seminomas

Area of Science:

• Veterinary Pathology
• Oncology
• Molecular Biology

Background:

• Altered iron metabolism is linked to cancer, but its role in canine tumors is understudied.
• Transferrin Receptor 2 (TfR2) regulates iron homeostasis and is a homolog of TfR1.
• Canine testicular tumors are common, yet the specific mechanisms driving their development are not fully understood.

Purpose of the Study:

• To investigate TfR2 immunohistochemical expression in normal canine testes and common canine testicular tumors.
• To determine if TfR2 expression patterns differ among various canine testicular tumor types.
• To explore the potential role of TfR2 in canine seminoma development and as a therapeutic target.

Main Methods:

• Immunohistochemistry was used to detect TfR2 expression.
• TfR2 was analyzed in non-neoplastic canine testes.
• TfR2 expression was evaluated in intratubular seminomas (ITSEMs), diffuse seminomas (DSEMs), Leydig cell tumors (LCTs), and Sertoli cell tumors (SCTs).

Main Results:

• TfR2 expression varied significantly across different canine testicular tumor types.
• High TfR2 expression was observed in both ITSEMs and DSEMs.
• TfR2 was occasionally expressed in LCTs and completely absent in SCTs.

Conclusions:

• TfR2 expression patterns suggest a significant role in the development of canine seminomas.
• The differential expression of TfR2 highlights its potential as a specific therapeutic target for canine seminomas.
• Further research into TfR2's function in iron regulation and compensatory mechanisms within these tumors is warranted.